DCIS and LCIS are named almost identically, and both contain the words “carcinoma in situ” — yet doctors understand them quite differently. DCIS, which starts in a milk duct, is treated as the earliest form of breast cancer, stage 0. LCIS, which starts in the lobules, is usually described not as a cancer in itself but as a sign that the risk of developing breast cancer in the future — in either breast — is higher than average. That difference in meaning is why two findings with such similar names lead to such different follow-up plans.
Key Takeaways
- DCIS starts in a milk duct; LCIS starts in a lobule, one of the glands that make milk. Both are “in situ,” meaning the cells have stayed where they began.
- DCIS is considered stage 0 breast cancer and is treated because some of it may become invasive in the same area over time.
- LCIS is usually viewed as a risk marker: it signals a higher chance of breast cancer developing later, in either breast, rather than being a cancer that will itself spread.
- DCIS is typically found on a mammogram; LCIS is usually found by chance, when a biopsy is done for another reason.
- Follow-up differs accordingly — treatment discussions for DCIS, monitoring and risk discussions for LCIS — and both are tailored to the individual.
Similar Names, Different Findings
The shared part of the names — “carcinoma in situ” — tells you one thing: in both findings, unusual cells are still inside the small structure where they started and have not grown into surrounding tissue. In situ is Latin for “in its original place.” Neither DCIS nor LCIS can travel to lymph nodes or other parts of the body.
Everything after that diverges: the structure involved, what the finding signals, and what doctors do about it. If you have received one of these names and feel confused about why your plan sounds different from someone else’s, the naming overlap is usually the reason. Our pillar guide to types of breast cancer compared shows where both findings sit in the overall classification.
Where Each One Starts
DCIS — ductal carcinoma in situ — begins in the lining of a milk duct. The changed cells fill part of the duct but remain inside its wall. Pathologists also grade DCIS cells by how different they look from normal cells, because grade is one of the details used when discussing how to manage it. Our explainer on ductal carcinoma in situ covers how DCIS appears on a report.
LCIS — lobular carcinoma in situ — begins in a lobule, the small gland where milk is made. The changed cells fill and slightly expand the lobule but stay inside it. There are subtypes of LCIS described by how the cells look, and one less common pattern is discussed more actively than the usual type; your report and your doctor can explain which description applies to you. Our explainer on lobular carcinoma in situ goes through the wording in detail.
DCIS and LCIS, Side by Side
| DCIS | LCIS | |
|---|---|---|
| Starting place | A milk duct | A lobule (milk-producing gland) |
| How it is usually described | The earliest form of breast cancer; stage 0 | A risk marker — a sign of higher future risk, rather than a cancer itself |
| How it is usually found | On a screening mammogram, often as small calcium specks | Usually by chance, in tissue biopsied for another reason |
| What it signals | A chance that invasive cancer could develop in the same area over time if it is not addressed | A higher chance of breast cancer developing later, in either breast and of more than one type |
| General direction of next steps | Treatment of the area is usually discussed | Careful monitoring and risk-reduction discussions are typical |
| Can it spread as it is? | No — cells are contained in the duct | No — cells are contained in the lobule |
How Each One Is Found
DCIS often announces itself on a screening mammogram as calcifications — tiny specks of calcium that can collect in a duct where cells are changing. A biopsy of that area confirms the diagnosis. Most people with DCIS feel nothing unusual in the breast.
LCIS, by contrast, usually produces no sign on a mammogram and no lump. It is most often an incidental finding: tissue is removed or sampled because of some other finding — a lump, a different imaging concern — and the pathologist notices LCIS in that tissue under the microscope. Being told about a finding nobody was looking for can feel unsettling, and it is reasonable to take time to understand what it does and does not mean.
What Each One Means for the Future
For DCIS, the concern is local and specific. If DCIS is left entirely unaddressed, some of it may develop into invasive cancer in the same part of the same breast over time — and there is no test that can identify in advance which areas will change. That possibility, weighed alongside the grade and size of the finding, is why treatment is generally discussed rather than simple watching.
For LCIS, the concern is broader and more gradual. LCIS itself is not expected to turn into invasive cancer in that spot; instead, it tells doctors that breast tissue in general — in both breasts — has a higher-than-average chance of developing cancer in the coming years. Any future cancer is as likely to be ductal as lobular, and may appear in either breast. Published risk figures change as research is updated; for numbers, current figures are published by the American Cancer Society (cancer.org) and the National Cancer Institute (cancer.gov). The practical point is that LCIS changes the follow-up plan, not that cancer is certain — most people with LCIS do not develop breast cancer.
How Follow-Up Discussions Differ
Discussions after DCIS usually focus on treating the area: surgery to remove it is part of most conversations, and depending on the details, radiation or hormone-based treatment afterward may also be raised. The aim is to lower the chance of the finding returning or an invasive cancer developing in that breast.
Discussions after LCIS usually focus on surveillance and risk: regular mammograms and check-ins on a schedule your doctor suggests, attention to any new breast changes, and a conversation about whether medicines that lower risk are worth considering in your situation, alongside general lifestyle factors. Surgery is not the usual response to typical LCIS, though individual circumstances — such as the less common LCIS patterns or other findings nearby — can change that conversation. In both cases, these are descriptions of the usual shape of the discussion, not recommendations; your own plan comes from your report and your team.
Questions to Ask Your Doctor
- Which finding do I have, and in which breast and area was it found?
- If it is DCIS, what grade is it, and how large is the area involved?
- If it is LCIS, which pattern was described, and does that change anything about follow-up?
- What follow-up schedule do you recommend for me, and what changes should I report between visits?
- Are risk-reducing medicines something we should discuss in my case?
- Does my family history change how you interpret this finding?
- Can you explain the difference between this finding and invasive cancer, in terms of my report?
Frequently Asked Questions
Is LCIS actually cancer?
Despite the word “carcinoma” in its name, LCIS is generally not treated as a cancer. It is a collection of changed cells inside a lobule that signals a higher future risk of breast cancer. The name is historical, which is a large part of why the two findings are so often confused. Your doctor can confirm how your own LCIS finding is classified.
Is DCIS stage 0 cancer?
Yes. DCIS is classified as stage 0 — the earliest stage — because the cells have the appearance of cancer but have not invaded surrounding tissue. Our overview of breast cancer stages 0 to 4 explains how stage 0 fits with the other stages.
Can LCIS itself turn into invasive cancer?
Typical LCIS is not thought to be a direct stepping stone to invasive cancer in the same spot, the way DCIS may be. Instead, it marks a general increase in risk across both breasts. That distinction is the main reason LCIS is usually managed with monitoring rather than treatment of the area.
Do both findings need surgery?
Not necessarily. Surgery to remove the area is part of most DCIS discussions. For typical LCIS, surgery is not usually advised on its own, though a biopsy finding of LCIS sometimes leads to a discussion about removing a little more tissue to be sure nothing else is nearby. Individual reports differ, so this is a question for your own team.
If I have LCIS, will I definitely get breast cancer?
No. LCIS raises the chance compared with average, but most people with LCIS never develop breast cancer. The finding is a reason for a thoughtful monitoring plan, not a prediction. Try not to compare your situation with anyone else’s — the rest of your health history matters too.
Where can I read more about these findings?
The American Cancer Society publishes clear explanations of both DCIS and LCIS, including how each is usually followed.
Related Articles
- Types of Breast Cancer Compared — the complete guide to how breast cancer types are classified and how they differ.
- What Is Ductal Carcinoma in Situ (DCIS)? — how DCIS is found, graded, and described on a report.
- What Is Lobular Carcinoma in Situ (LCIS)? — what an LCIS finding means and how it is usually followed.
- In Situ vs Invasive Breast Cancer — the meaning of “in situ” across all breast findings.
- DCIS vs Invasive Ductal Carcinoma — what changes when ductal cancer grows beyond the duct.
This article is for general educational purposes only and is not medical, legal, or financial advice. It does not replace professional care. Talk to your doctor or care team about your own situation. If you think you may have a medical emergency, call 911.